Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

News > Suppliers

Read more breaking news



Nestlé quiet on latest Danone medical nutrition takeover 'market rumors'

By Mark Astley+


Nestlé quiet on Danone medical nutrition takeover 'market rumors'

Nestlé has declined to comment on "market rumors" that it is in advanced talks with Danone to acquire the French dairy's medical nutrition division.

Numerous news outlets, citing sources close to the companies, have reported that Danone is in talks with Switzerland-based Nestlé regarding the sale of its medical nutrition business.

It was reported in February 2014 that Paris-based Danone had called in financial services provider JP Morgan to advise on potential buyers.

Abbott Laboratories, Nestlé, Baxter and Fresenius were among those initially pinpointed as potential suitors. But with main rival Fresenius now reportedly out of the race, Nestlé is favorite to acquire the business division.

Approached by, Nestlé declined to provide comment on what it described as "market rumors."

"As a matter of principle, we do not comment on market rumors," said Philippe Aeschlimann, corporate spokesman at Nestlé.

Danone provided a similar response, telling "We have no comment on these reports."

€3bn price tag?

Danone’s medical nutrition division manufactures products for those weakened by illness or chronic conditions.

Its portfolio includes liquid food for hospital patients unable to eat solids, food supplements for elderly people with failing appetites, and products for those that suffer from allergies.

It was reported in February that the business could fetch up to €3bn (US$4.1bn).

In recent years, the division has reported a slow in growth, which Danone attributed in 2012 to "deteriorating conditions in some markets in Western Europe."

For the first quarter of 2014, however, the business segment reported sales of €328m (US$450m) - a 5.2% like-for-like increase. Danone attributed result to "a stronger boost from pediatric care brands" and improved sales in Turkey, the UK, the Middle East and North America. 

It has been suggested that cashing in on its medical nutrition division would enable Danone to focus on its infant nutrition and fresh dairy products divisions, which have been impacted by declining consumption in Europe and reputation issues in Asia.

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Balancing Innovation and Risk in Sports Nutrition Ingredients
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars